Mannello F, Luchetti F, Falcieri E, Papa S. Multiple roles of matrix metalloproteinases during apoptosis. Apoptosis. 2005;10(1):19–24.

Article  CAS  PubMed  Google Scholar 

Soleimani Z, Kheirkhah D, Sharif MR, Sharif A, Karimian M, Aftabi Y. Association of CCND1 Gene c. 870G> A polymorphism with breast cancer risk: A case-controlstudy and a meta-analysis. Pathology & Oncology Research. 2017;23:621–31.

Article  CAS  Google Scholar 

Safabakhsh M, Imani H, Shab-Bidar S. Higher dietary total antioxidant capacity is not associated with risk of breast cancer in Iranian women. Breast Cancer. 2020;27(4):652–61.

Article  PubMed  Google Scholar 

Hojilla C, Mohammed F, Khokha R. Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development. Br J Cancer. 2003;89(10):1817–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Folgueras AR, Pendas AM, Sánchez LM, Lopez-Otin C. Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol. 2004;48(5–6):411–24.

Article  CAS  PubMed  Google Scholar 

Jiang Y, Goldberg ID, Shi YE. Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene. 2002;21(14):2245–52.

Article  CAS  PubMed  Google Scholar 

Woessner JF, Woessner JF, Nagase H. Matrix metalloproteinases and TIMPs. Oxford University Press; 2000.

Book  Google Scholar 

Jiang Y, Wang M, Çeliker MY, Liu YE, Amy Sang QX, Goldberg ID, et al. Stimulation of mammary tumorigenesis by systemic tissue inhibitor of matrix metalloproteinase 4 gene delivery. Can Res. 2001;61(6):2365–70.

CAS  Google Scholar 

Guedez L, McMarlin AJ, Kingma DW, Bennett TA, Stetler-Stevenson M, Stetler-Stevenson WG. Tissue inhibitor of metalloproteinase-1 alters the tumorigenicity of Burkitt’s lymphoma via divergent effects on tumor growth and angiogenesis. Am J Pathol. 2001;158(4):1207–15.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Murphy AN, Unsworth EJ, Stetler-Stevenson WG. Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. J Cell Physiol. 1993;157(2):351–8.

Article  CAS  PubMed  Google Scholar 

Gu X, Fu M, Ding Y, Ni H, Zhang W, Zhu Y, et al. TIMP-3 expression associates with malignant behaviors and predicts favorable survival in HCC. PLoS ONE. 2014;9(8): e106161.

Article  PubMed  PubMed Central  Google Scholar 

Su CW, Huang YW, Chen MK, Su SC, Yang SF, Lin CW. Polymorphisms and plasma levels of tissue inhibitor of metalloproteinase-3: impact on genetic susceptibility and clinical outcome of oral cancer. Medicine. 2015;94(46):PMC4652830.

Article  Google Scholar 

Wu D-W, Tsai L-H, Chen P-M, Lee M-C, Wang L, Chen C-Y, et al. Loss of TIMP-3 promotes tumor invasion via elevated IL-6 production and predicts poor survival and relapse in HPV-infected non–small cell lung cancer. Am J Pathol. 2012;181(5):1796–806.

Article  CAS  PubMed  Google Scholar 

Yu JL, Lv P, Han J, Zhu X, Hong LL, Zhu WY, Wang XB, Wu YC, Li P, Ling ZQ. Methylated TIMP-3 DNA in body fluids is an independent prognostic factor for gastric cancer. Arch Pathol Lab Med. 2014;138(11):1466–73.

Article  PubMed  Google Scholar 

Lee TI, Young RA. Transcriptional regulation and its misregulation in disease. Cell. 2013;152(6):1237–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Darnton SJ, Hardie LJ, Muc RS, Wild CP, Casson AG. Tissue inhibitor of metalloproteinase-3 (TIMP-3) gene is methylated in the development of esophageal adenocarcinoma: loss of expression correlates with poor prognosis. Int J Cancer. 2005;115(3):351–8.

Article  CAS  PubMed  Google Scholar 

Brew K, Nagase H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochimica et biophysica acta (BBA-) molecular cell research. 2010;1803(1):55–71.

Article  CAS  PubMed  Google Scholar 

Yu W-H, Shuan-su CY, Meng Q, Brew K, Woessner JF. TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix. J Biol Chem. 2000;275(40):31226–32.

Article  CAS  PubMed  Google Scholar 

Wang K, Wang G, Huang S, Luo A, Jing X, Li G, et al. Association between TIMP-2 gene polymorphism and breast cancer in Han Chinese women. BMC Cancer. 2019;19(1):446.

Article  PubMed  PubMed Central  Google Scholar 

Peterson NB, Beeghly-Fadiel A, Gao YT, Long J, Cai Q, Shu XO, et al. Polymorphisms in tissue inhibitors of metalloproteinases-2 and -3 and breast cancer susceptibility and survival. Int J Cancer. 2009;125(4):844–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rundhaug JE. Matrix metalloproteinases and angiogenesis. J Cell Mol Med. 2005;9(2):267–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jezierska A, Motyl T. Matrix metalloproteinase-2 involvement in breast cancer progression: a mini-review. Med Sci Mon Int Med J Exp Clin Res. 2009;15(2):32–40.

Google Scholar 

Roberts LM, Visser JA, Ingraham HA. Involvement of a matrix metalloproteinase in MIS-induced cell death during urogenital development. Development (Cambridge, England). 2002;129(6):1487–96.

Article  CAS  PubMed  Google Scholar 

Jezierska A, Matysiak W, Motyl T. ALCAM/CD166 protects breast cancer cells against apoptosis and autophagy. Med Sci Mon Int Med J Exp Clin Res. 2006;12(8):Br263–73.

CAS  Google Scholar 

Jezierska A, Olszewski WP, Pietruszkiewicz J, Olszewski W, Matysiak W, Motyl T. Activated Leukocyte Cell Adhesion Molecule (ALCAM) is associated with suppression of breast cancer cells invasion. Medical science monitor : international medical journal of experimental and clinical research. 2006;12(7):Br245–56.

CAS  PubMed  Google Scholar 

Hu YB, Li DG, Lu HM. Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats. J Gene Med. 2007;9(3):217–29.

Article  CAS  PubMed  Google Scholar 

Su CW, Lin CW, Yang WE, Yang SF. TIMP-3 as a therapeutic target for cancer. Therap Adv Med Oncol. 2019;11:1758835919864247.

CAS  Google Scholar 

Karimian M, Behjati M, Barati E, Ehteram T, Karimian A. CYP1A1 and GSTs common gene variations and presbycusis risk: a genetic association analysis and a bioinformatics approach. Environ Sci Pollut Res Int. 2020;27(34):42600–10.

Article  CAS  PubMed  Google Scholar 

Karimian M, Momeni A, Farmohammadi A, Behjati M, Jafari M, Raygan F. Common gene polymorphism in ATP-binding cassette transporter A1 and coronary artery disease: a genetic association study and a structural analysis. J Cell Biochem. 2020;121(5–6):3345–57.

Article  CAS  PubMed  Google Scholar 

Bafrani HH, Ahmadi M, Jahantigh D, Karimian M. Association analysis of the common varieties of IL17A and IL17F genes with the risk of knee osteoarthritis. J Cell Biochem. 2019;120(10):18020–30.

Article  CAS  PubMed  Google Scholar 

Mobasseri N, Nikzad H, Karimian M. Protective effect of oestrogen receptor α-PvuII transition against idiopathic male infertility: a case-control study and meta-analysis. Reprod Biomed Online. 2019;38(4):588–98.

Article  CAS  PubMed  Google Scholar 

Noureddini M, Mobasseri N, Karimian M, Behjati M, Nikzad H. Arg399Gln substitution in XRCC1 as a prognostic and predictive biomarker for prostate cancer: evidence from 8662 subjects and a structural analysis. J Gene Med. 2018;20(10–11): e3053.

Article  PubMed  Google Scholar 

Karimian M, Aftabi Y, Mazoochi T, Babaei F, Khamechian T, Boojari H, et al. Survivin polymorphisms and susceptibility to prostate cancer: a genetic association study and an in silico analysis. EXCLI J. 2018;17:479–91.

PubMed  PubMed Central  Google Scholar 

Zamani-Badi T, Nikzad H, Karimian M. IL-1RA VNTR and IL-1α 4845G>T polymorphisms and risk of idiopathic male infertility in Iranian men: a case-control study and an in silico analysis. Andrologia. 2018;50(9): e13081.

Article  PubMed  Google Scholar 

Ebrahimi A, Hosseinzadeh Colagar A, Karimian M. Association of human methionine synthase-A2756G transition with prostate cancer: a case-control study and in silico analysis. Acta Med Iran. 2017;55(5):297–303.

PubMed  Google Scholar 

Karimian M, Nikzad H, Azami-Tameh A, Taherian A, Darvishi FZ, Haghighatnia MJ. SPO11-C631T gene polymorphism: association with male infertility and an in silico-analysis. J Family Reprod Health. 2015;9(4):155–63.

PubMed  PubMed Central  Google Scholar 

Karimian M, Ghazaey Zidanloo S, Jahantigh D. Influence of FOXP3 gene polymorphisms on the risk of preeclampsia: a meta-analysis and a bioinformatic approach. Clin Exp Hypertens. 2022;44(3):280–90.

Article  CAS  PubMed  Google Scholar